TACE group:TACE

2 trials

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine, First Affiliated Hospital of Zhengzhou University

Conditions

Hepatocellular carcinoma

Phase 4

Variance analysis of hepatic functional reserve in TACE and TACE combined with Sorafenib for HCC

Active, not recruitingChiCTR-ONRC-12002277

First Affiliated Hospital of Zhengzhou UniversityHepatocellular carcinoma

Start: 2012-09-01Updated: 2017-04-18

Unknown Phase

A randomized controlled trial of hepatectomy vesus transcatheter arterial chemoembolization for UICC T3 hepatocellular carcinoma

Active, not recruitingChiCTR2000033549

The First Affiliated Hospital of Guangzhou University of Chinese MedicineHepatocellular carcinoma

Start: 2020-06-15Updated: 2020-06-08